Under construction – not a live service
Sign in
Taking peopleNo phase

Prospective Study of Arthrodesis of Finger Distal Interphalangeal Joints Using the Kerifuse Device

Key facts

Who runs it
Clinique Saint François, Nice, France
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
1 Dec 2023
Expected to end
1 Dec 2027
Type of study
Interventional
Treatments tested
  • KeriFuse implant implantation
Record updated
10 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Eligible patients with osteoarthritis of finger for an interphalangeal arthrodesis with KeriFuse implant

Who cannot take part

  • Patients with contraindications to surgery
  • Patients with acute or chronic, local or systemic infections
  • Patients with sensitivities or allergies to device components (Nickel, Titanium)
  • Pregnant or breastfeeding patient
  • Patient with an intellectual disability and who therefore cannot follow the surgeon's instructions

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Arthrodesis of a distal interphalangeal joint of the finger (DIP) is mainly performed for a degenerated and painful joint. Various stabilization methods have been used to provide compression at the arthrodesis site such as pins, steel wires, compression screws, headless compression screws, bioresorbable implants and intramedullary staples.

Read full original descriptionShow less

Although with complications such as implant fractures or dorsal cortical erosion, intramedullary arthrodesis staples provide reliable pain relief and a consistent fusion rate while inevitably scarring the finger pulp or nail dystrophy.

The aim of this study is to evaluate the bone fusion time during an arthrodesis performed with the Kerifuse shape memory implant.

The group in the trial

  • PatientsTreatment being tested

    Patients older than 18 years-old, with a surgical indication of interphalangeal arthrodesis of finger

    Treatment: KeriFuse implant implantation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective Study of Arthrodesis of Finger Distal Interphalangeal Joints Using the Kerifuse Device KF 23)
Record updated
10 July 2026